vTv Therapeutics (VTVT) Other Accumulated Expenses (2014 - 2021)

vTv Therapeutics has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $155000.0 for Q4 2021.

• Other Accumulated Expenses for Q4 2021 came in at $155000.0, up 675.0% year-over-year; the trailing twelve-month figure through Dec 2021 was $155000.0 (up 675.0% YoY), and the FY2021 annual result was $155000.0, up 675.0% from the prior year.
• Other Accumulated Expenses came in at $155000.0 for Q4 2021 at vTv Therapeutics, up from $20000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q4 2017 to a low of $20000.0 in Q4 2020.
• The 5-year median for Other Accumulated Expenses is $142000.0 (2018), against an average of $300400.0.
• Across the five-year window, Other Accumulated Expenses sank 86.55% in 2018 and surged 675.0% in 2021, its largest moves.
• vTv Therapeutics' Other Accumulated Expenses stood at $1.1 million in 2017, then tumbled by 86.55% to $142000.0 in 2018, then decreased by 9.15% to $129000.0 in 2019, then slumped by 84.5% to $20000.0 in 2020, then soared by 675.0% to $155000.0 in 2021.
• The last three Other Accumulated Expenses figures came in at $155000.0 (Q4 2021), $20000.0 (Q4 2020), and $129000.0 (Q4 2019), per Business Quant data.